Please ensure Javascript is enabled for purposes of website accessibility

FDA advisers back Pfizer’s COVID-19 vaccine for young kids (access required)

A panel of U.S. health advisers endorsed kid-size doses of Pfizer’s COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11.